SEC Tightens Cybersecurity Requirements with Regulation S-P Amendments

05 June 2024

Health Care Law Today

Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates

Antibody-drug conjugates are a promising class of cancer treatments with an accelerating number of U.S. Food and Drug Administration approvals and rapidly growing market size, as discussed in previous articles in this series.